PURE BIOSCIENCE, INC.
Last · —$0.07-0.01 (-12.50%)live · yahoo · 1h ago
Market cap$10.39M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $2.4M |
|---|---|
| Operating income | $-1.6M |
| Net income | $-1.9M |
| Operating margin | -65.2% |
| Net margin | -77.3% |
| Period | TTM 2026-04-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2025-10-29
- Going Concern
- Cash Burn
- Related Party Debt
- Customer Concentration
- Third Party Manufacturing
- Food Safety Adoption
Red flags
- Cumulative net loss reached approximately $139.0 million by July 31, 2025, with a stockholders deficiency of $5.116 million.
- Convertible notes payable to related parties totaled $5.236 million including accrued interest; Tom Lee, a director, funded $3.785 million of 2024 and 2025 notes and continued financing is not assured.
- Cash of $334,000 versus $2.015 million of fiscal 2025 operating cash burn indicates a material funding gap.
- One customer represented 18% of fiscal 2025 net product sales, and customer agreements generally lack minimum purchase obligations.